SELLAS Life Sciences Group, Inc.SLSNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank50
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-28.39M
Near historical average
Percentile
P50
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-25.94M
Historical baseline
PeriodValueYoY Change
2025$-28.39M+19.8%
2024$-35.40M-12.7%
2023$-31.41M-31.9%
2022$-23.81M+8.5%
2021$-26.02M-149.8%
2020$-10.42M+41.0%
2019$-17.64M+42.0%
2018$-30.42M-176.8%
2017$-10.99M+75.5%
2016$-44.91M-